Immunogenicity of indigenous recombinant hepatitis B vaccine in infants following a 0, 1, 2-month vaccination schedule.

Kumar, T SAbraham, PRaghuraman, SCherian, T2000-01-042009-05-272000-01-042009-05-272000-01-04Kumar TS, Abraham P, Raghuraman S, Cherian T. Immunogenicity of indigenous recombinant hepatitis B vaccine in infants following a 0, 1, 2-month vaccination schedule. Indian Pediatrics. 2000 Jan; 37(1): 75-80http://imsear.searo.who.int/handle/123456789/7114engConsumer Product SafetyDiphtheria-Tetanus-Pertussis Vaccine --pharmacologyHepatitis B --immunologyHepatitis B Vaccines --pharmacologyHumansImmunization ScheduleInfantInfant, NewbornVaccines, Synthetic --pharmacologyImmunogenicity of indigenous recombinant hepatitis B vaccine in infants following a 0, 1, 2-month vaccination schedule.Clinical Trial